Results 121 to 130 of about 4,120 (162)

Changes in serum phosphate concentrations in patients on maintenance dialysis following a change in the lanthanum carbonate formulation

open access: bronze, 2013
Yuko Itou   +8 more
openalex   +2 more sources

Whitish Deposits in the Stomach and Duodenum. [PDF]

open access: yesUnited European Gastroenterol J
Yang KY, Zhou XJ, Xie W.
europepmc   +1 more source

Barium lanthanum sulfide ceramics as new far-infrared transparent materials. [PDF]

open access: yesSci Rep
Le Coz A   +3 more
europepmc   +1 more source

Efficacy of tenapanor in managing hyperphosphatemia and constipation in hemodialysis patients: A randomized controlled trial. [PDF]

open access: yesPLoS One
Suzuki N   +12 more
europepmc   +1 more source

Lanthanum Carbonate

Hospital Pharmacy, 2005
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase 3 trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada   +2 more
openaire   +2 more sources

Lanthanum Carbonate

Drugs, 2004
Lanthanum carbonate is a novel, non-aluminium, non-calcium phosphate binding agent that forms a water-insoluble compound, lanthanum phosphate, in the gut. Lanthanum carbonate (elemental lanthanum 375-3000 mg/day) reduced serum phosphorus levels compared with placebo in two randomised, double-blind, multicentre 4-week trials in patients with chronic ...
Tracy, Swainston Harrison   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy